After submission to the regulatory authority, a substantial error was found in the application. In order to resolve this issue, what should be done FIRST?

According to the GHTF, which of the following is NOT an exemption rule when evaluating the decision to report an adverse event?

SOPs for preventive and corrective actions MUST include the procedure to eliminate which of the following?

What is the BEST approach to ensure that raw materials, services, and sub-contractors at the level of the vendors comply with GMP requirements?

A company's product was approved by a regulatory authority with the condition that further studies must be completed prior to full approval of the product.
To minimize product-associated risk to patients during the period of conditional approval, what is the LEAST effective way to achieve this goal?